As of 2025-10-18, the Relative Valuation of THC Biomed Intl Ltd (THC.CN) is (0.21) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of THC Biomed Intl Ltd based on Relative Valuation is -1135.8%.
The range of the Relative Valuation is (0.11) - (0.23) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.5x - 8.5x | 5.5x |
| Forward P/E multiples | 2.4x - 5.1x | 3.8x |
| Fair Price | (0.11) - (0.23) | (0.21) |
| Upside | -659.9% - -1242.2% | -1135.8% |
| Date | P/E |